Company: INKT
Filing Date: 2025-12-10
Form Type: S-3/A
Source: 0001193125-25-314252
Chunk: 24

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-12-10
Form: S-3/A
Chunk 24
---
 represent direct, unsecured obligations of the Company and will rank equally with all of our other unsecured indebtedness. The following statements relating to the debt securities and the indenture are summaries, qualified in their entirety by reference to the detailed provisions of the indenture and the final form indenture as may be filed with a future prospectus supplement. General We may issue the debt securities in one or more series with the same or various maturities, at par, at a premium, or at a discount. We will describe the particular terms of each series of debt securities in a prospectus supplement relating to that series, which we will file with the SEC. The prospectus supplement will set forth, to the extent required, the following terms of the debt securities in respect of which the prospectus supplement is delivered:

| • |     | the title of the series; |

| • |     | the aggregate principal amount; |

| • |     | the issue price or prices, expressed as a percentage of the aggregate principal amount of the debt securities; |

| • |     | any limit on the aggregate principal amount; |

| • |     | the date or dates on which principal is payable; |

| • |     | the interest rate or rates (which may be fixed or variable) or, if applicable, the method used to determine such 
 rate or rates;                                                                                                   |

| • |     | the date or dates from which interest, if any, will be payable and any regular record date for the interest 
 payable;                                                                                                    |

| • |     | the place or places where principal and, if applicable, premium and interest, is payable; |

18

| • |     | the terms and conditions upon which we may, or the holders may require us to, redeem or repurchase the debt 
 securities;                                                                                                 |

| • |     | the denominations in which such debt securities may be issuable, if other than denominations of $1,000 or any 
 integral multiple of that number;                                                                             |

| • |     | whether the debt securities are to be issuable in the form of certificated securities (as described below) or 
 global securities (as described below);                                                                       |

| • |     | the portion of principal amount that will be payable upon declaration of acceleration of the maturity date if 
 other than the principal amount of the debt securities;                                                       |

| • |     | the currency of denomination; |

| • |     | the designation of the currency, currencies or currency units in